8-K - Ensysce Biosciences, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Ensysce Biosciences, Inc. announced the resignation of director Curtis Rosebraugh from its Board of Directors, effective April 1, 2026.

Key Takeaways

1Director Curtis Rosebraugh resigned from the Board of Directors effective April 1, 2026.

2The resignation was not due to any disagreement with the Company, its management, the Board, or any committee.

3Dr. Rosebraugh served on the Nominating and Corporate Governance Committee until his resignation.

4The resignation notice was formally attached as Exhibit 17 to the filing.

Current Report Details

Event Type

Management Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | |---|---|

Management Change

9.01

| Financial Statements and Exhibits. | |---|---| (d) Exhibits . | Exhibit No. | | Description | |---|---|---| | 17 | | Resignation dated April 1, 2026 | | 104 |

Exhibits Only

Executive & Director Changes

Curtis Rosebraugh

Member of the Board of Directors

Resignation

Effective: 2026-04-01

Not as a result of any disagreement between myself and the Company, its management, the Board or any committee of the Board.

Exhibits (2)

EX-17

8-K